Phase II trial of gevokizumab in patients with acute gout.
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2008
At a glance
- Drugs Gevokizumab (Primary)
- Indications Gout
- Focus Therapeutic Use
- Sponsors XOMA
- 31 Dec 2008 Status changed from planning to suspended
- 06 Jun 2008 New trial record.